Skip to main content
PLOS One logoLink to PLOS One
. 2021 Oct 13;16(10):e0258500. doi: 10.1371/journal.pone.0258500

Chlamydia buteonis in birds of prey presented to California wildlife rehabilitation facilities

Brittany A Seibert 1,¤, Michael K Keel 2,#, Terra R Kelly 3, Roger A Nilsen 4, Paula Ciembor 4, Denise Pesti 4, Christopher R Gregory 4, Branson W Ritchie 4,#, Michelle G Hawkins 5,*,#
Editor: Deborah Dean6
PMCID: PMC8513822  PMID: 34644359

Abstract

Chlamydial infections, caused by a group of obligate, intracellular, gram-negative bacteria, have health implications for animals and humans. Due to their highly infectious nature and zoonotic potential, staff at wildlife rehabilitation centers should be educated on the clinical manifestations, prevalence, and risk factors associated with Chlamydia spp. infections in raptors. The objectives of this study were to document the prevalence of chlamydial DNA shedding and anti-chlamydial antibodies in raptors admitted to five wildlife rehabilitation centers in California over a one-year period. Chlamydial prevalence was estimated in raptors for each center and potential risk factors associated with infection were evaluated, including location, species, season, and age class. Plasma samples and conjunctiva/choana/cloaca swabs were collected for serology and qPCR from a subset of 263 birds of prey, representing 18 species. Serologic assays identified both anti-C. buteonis IgM and anti-chlamydial IgY antibodies. Chlamydial DNA and anti-chlamydial antibodies were detected in 4.18% (11/263) and 3.14% (6/191) of patients, respectively. Chamydial DNA was identified in raptors from the families Accipitridae and Strigidae while anti-C.buteonis IgM was identified in birds identified in Accipitridae, Falconidae, Strigidae, and Cathartidae. Two of the chlamydial DNA positive birds (one Swainson’s hawk (Buteo swainsoni) and one red-tailed hawk (Buteo jamaicensis)) were necropsied, and tissues were collected for culture. Sequencing of the cultured elementary bodies revealed a chlamydial DNA sequence with 99.97% average nucleotide identity to the recently described Chlamydia buteonis. Spatial clusters of seropositive raptors and raptors positive for chlamydial DNA were detected in northern California. Infections were most prevalent during the winter season. Furthermore, while the proportion of raptors testing positive for chlamydial DNA was similar across age classes, seroprevalence was highest in adults. This study questions the current knowledge on C. buteonis host range and highlights the importance of further studies to evaluate the diversity and epidemiology of Chlamydia spp. infecting raptor populations.

Introduction

Chlamydiae are obligate intracellular, gram-negative bacteria responsible for a variety of diseases in multiple species, including humans [1]. One example, Chlamydia psittaci, is a cosmopolitan chlamydial species and important zoonotic pathogen. This organism has a global distribution and has been reported in > 469 bird species encompassing 30 orders [2,3]. Currently, there are 14 recognized and 3 candidate species in the genus Chlamydia [49], including the newly identified C. buteonis [10].

There are relatively few reports of chlamydial infections in raptors in the United States [1114]. In 1983, C. psittaci was isolated from four red-tailed hawks (Buteo jamaicensis; RTHA) in northern California (CA) and in 1992, C. psittaci was cultured from a RTHA in Louisiana with respiratory distress and diarrhea [11,12]. A recent study reported a 1.37% prevalence of chlamydial DNA in free-ranging raptors in northern CA, although anti-chlamydial antibodies using an elementary body agglutination (EBA) assay were not identified in any bird [14]. In Oregon, 3.6% of raptors at rehabilitation centers were positive for C. psittaci DNA [13]. In 2019 a red-shouldered hawk (Buteo lineatus; RSHA), one of 12 birds in an enclosure, developed conjunctivitis and died. Antemortem and postmortem testing including whole genome sequencing identified a novel chlamydial organism with C. psittaci and C. abortus as closest relatives and it was proposed that this novel organism be identified as C. buteonis, RSHA strain [10].

Chlamydiaceae species have significant impacts on human and animal health worldwide [15,16]. Recent discoveries of new species such as C. buteonis highlights major gaps in our understanding of host range, diversity and pathogenicity of Chlamydiaceae family members. Continued characterization of novel chlamydial organisms provides evidence that additional species may be pathogenic and pose zoonotic risks [15,17]. Recent expansions in their known host range highlight the risk for spill-over infections with increasing contact between wildlife, livestock, and humans because of greater wildlife habitat encroachment, intensification of livestock production, and pet ownership [15,17]. Most human cases of C. psittaci have been linked to companion birds, but some are linked to free-living birds [18,19]. A C. psittaci genotype identified from a raptor at a Belgian refuge was also cultured from three human contacts; one person reported symptoms consistent with chlamydiosis [19]. Chlamydia psittaci can be transmitted via ingestion or inhalation of ocular and nasal discharges and droppings from infected birds leading to risk of outbreaks at rehabilitation centers [2022]. However, for many chlamydial species, modes of transmission are still unclear.

Diagnosis of chlamydial infections is challenging due to the absence or variability of clinical signs; multi-modal diagnostic testing is recommended for confirmatory diagnosis [23]. Isolation in cell culture was considered the gold standard until recently; now PCR-based detection is considered the gold standard for chlamydial diagnostics [24,25]. Samples are collected from epithelial surfaces that shed C. psittaci (e.g., conjunctiva, choana, and cloaca) or from infected tissues such as liver, lung, air sac, and spleen [23,26,27]. Additional testing includes serology using paired serum samples collected from acute- and convalescent- phase patients obtained at least 2 weeks apart and tested in the same laboratory at the same time [23]. Commercially available EBA assays detect C. psittaci IgM, while indirect fluorescent antibody tests (IFA) detect Chlamydia spp. IgY at the genus level [23]. As a result, serology can lead to conflicting results based on chlamydial species and time of sample collection.

To our knowledge there are no studies assessing detection of chlamydial DNA and seroprevalence in raptors admitted to wildlife rehabilitation centers in the US. Additionally, investigations of infection risk factors are lacking in wild birds. The objectives of this study were to evaluate the prevalence of chlamydial DNA shedding and seroprevalence in raptors admitted to five wildlife rehabilitation centers throughout CA over a one-year period and to explore risk factors associated with infection.

Materials and methods

Ethics statement

This study was approved by the Institute of Animal Care and Use Committee of the University of California, Davis (protocol #19119).

Sample collection

All raptors presenting to five CA wildlife rehabilitation centers from April 2016 to May 2017 were sampled. The following centers participated in the study and represented northern, central and southern CA: (1) California Raptor Center (CRC; Davis, northern CA), (2) Pacific Wildlife Care (PWC; Morro Bay, central CA), (3) Monterey SPCA (MSPCA; Monterey, central CA), (4) Living Desert Zoo Rehabilitation Center (LD; Palm Desert, southern CA), and (5) California Wildlife Center (CWC; Calabasas, southern CA). Criteria for inclusion included permissions from California Department of Fish and Wildlife to collect diagnostic samples from raptors, an on-site veterinarian for sample collection and an average intake of 200+ raptors/year. Veterinarians performed a full physical examination on each raptor at admission and recorded their findings, admission date, location found, species, sex, age class, and reason for admission. Conjunctival, choanal, and cloacal (c/c/c) mucosal swabs were obtained using a sterile, rayon-tipped swab (Puritan, 25–806 1PR). The swab tip was placed in a sterile 1.5 ml Eppendorf tube and stored at -20° C until shipment. Every three months, swabs were shipped overnight to the Infectious Disease Laboratory, University of Georgia (IDL) for quantitative real-time polymerase chain reaction (qPCR) to detect Chlamydia spp. DNA. Whole blood was collected from the jugular or medial metatarsal veins. Blood samples were placed into lithium heparin tubes and centrifuged at 3800 x g for 6 minutes. Plasma was collected into two cryovials and stored at -20°C pending shipment. Every three months, plasma was shipped overnight to the University of California, Davis and stored at -80°C until overnight shipment to the IDL. One aliquot of plasma was tested for chlamydial antibodies using elementary bodies purified from a RTHA (IDL17_4553_RTH) and Swainson’s hawk [Buteo swainsonii; SWHA]) (IDL16-5840_SH) hawk Chlamydia buteonis isolate at the IDL. A second aliquot was shipped to the Avian and Wildlife Laboratory, University of Miami (AWL) for Chlamydia genus-specific IFA.

Two birds (one RTHA [(IDL17_4553_RTH)] and one SWHA [IDL16-5840_SH]) admitted to the CRC exhibited clinical signs suggestive of chlamydial infection. Both birds were positive by Chlamydia spp. DNA via qPCR and subsequently euthanized. Necropsies were performed within 12 hours. Lung, liver, spleen and air-sac tissues were collected for culture using aseptic technique. Tissues were placed in cryovials with sterile saline, and shipped overnight on ice to the IDL for chlamydial culture [27,28].

Culture

Tissue samples from two birds were disrupted on the Mini Bead Mill (VWR) using 1.5ml tubes pre-filled with 2.4mm metal beads (VWR 10158–598). Filtration using a 0.45 um filter syringe was performed on tissue homogenates and inoculated on Vero-cell monolayers with DMEM (Corning 10-013-CV) supplemented with non-essential amino acids and 10% fetal calf serum according to previously published protocols [3,27]. Cell cultures with suggestive cytopathic effects (CPE) were tested for chlamydial DNA via qPCR. Briefly, 1uL of heat-inactivated cell culture supernatant was tested for Chlamydia spp. DNA via the ompA qPCR described previously [27,28]. Positive cultures from the SWHA (IDL16-5840_SH) and RTHA (IDL17_4553_RTH) went through six passages to obtain nearly 100% CPE to maximize the concentration of infectious elementary bodies (EB) for isolation. DNA was extracted from purified EBs using a nucleic acid purification extraction (QuickExtract, Epicentre Biotechnologies, Madison, WI) according to manufacturer’s instructions and frozen at -80°C until sequencing.

Sequencing and bioinformatic analysis

Chlamydial DNA was submitted for high throughput sequencing to the Centers for Disease Control and Prevention. The NEB Next Ultra DNA library prep kit for Illumina (New England Biolabs, Ipswich, MA) was used to prepare gDNA libraries according to the manufacturer’s protocol. Genome sequencing was performed on the isolates using the Illumina MiSeq desktop sequencer (Illumina, San Diego, CA). Illumina sequencing read quality was evaluated using FastQC program (v0.10.1) [29]. Processing was performed with Cutadapt (v1.5) [30] and reads were removed from the data set if they met one of the following criteria: (a) had low quality (< 25) sequence bases; (b) trimmed adapter sequences; (c) had an error rate above 0.03; or (d) less than 75 base pairs in length. De novo assembly was performed with VelvetOptimiser v2.2.5 and Velvet v1.2.10 [31]. Long read sequencing was performed using the Pacific Biosciences (PacBio) RS II (Pacific Biosciences, Menlo Park, CA). One or two SMRT cells were used for each isolate with a movie time of 240 minutes. The sequences were assembled with SMRT Analysis v2.2 Hierarchical Genome Assembly Process version 2 (HGAP 2) or 3 (HGAP 3) protocol. The Illumina sequencing data associated with each isolate was aligned to the long read PacBio assembly for nucleotide accuracy comparison. Average nucleotide identity (ANI) was determined using program Pyani (v0.2.10) with default settings [32]. A maximum-likelihood phylogenomic tree was computed using IQTree [33] + ModelFinder [34] with 1000 iterations of bootstrapping from a pan-genomic analysis using Anvi’o [35] based on aligned protein sequences from all shared single copy gene clusters. Anvi’o software identified 742 single copy genes that were distinguishable as homologous among all genomes and used for further phylogenetic analysis. Sequences (SWHA (IDL16-5840_SH) and RTHA (IDL17_4553_RTH) were submitted to NCBI BioProject accession number PRJNA613727.

Quantitative PCR

Swabs were processed for DNA extraction by boiling samples for 5 minutes in buffered saline solution containing dithiothreitol (DTT). Initially, standard target DNA amplification of the ompA sequence for C. psittaci qPCR with melting curve analysis was executed using the LightCycler 480 System and probe detection as previously described [27,36]. Although positive samples were amplified using C. psittaci primers, the melting curve analysis of the amplicon showed that the curve Tm and shape was unique from C. psittaci positive-control samples, thus the samples were determined as “atypical”. To further identify the “atypical” positive samples, extracted DNA was amplified by targeted PCR for C. buteonis using primers 17473F (AGCTCACATCATCGCTCTCG) and 17937R (TGCGTGTTGTCGAACTAGCT) followed by gel electrophoresis. Further, Sanger sequencing was performed by Genewiz (South Plainfield, NJ) to confirm the identity of C. buteonis PCR products, which aligned to C. buteonis with 100% identity.

Serology

All plasma samples were evaluated for antibodies using isolate-specific EBA serology [36]. The EBs from RTHA (IDL17-4553) were obtained by centrifuging infected Vero cells at 46,467 x G for 1 h. The pellet was washed in Opti-MEM (Thermo Fisher, Grand Island, NY) and centrifuged at 1,200 x G for 5 min. The EBs were inactivated, layered on renografin, and centrifuged at 60,226 x G for 90 min. The band containing EBs was attained, pelleted, and resuspended in diluent to a working concentration as described previously [36]. A suspension of EBs was mixed with unknown plasma samples on a slide by a mechanical rotator for 3 minutes at 150 rpm [37]. Samples were seropositive if agglutination was present [37]. Antibody titers were recorded as the highest serum dilution with agglutination, if there was no agglutination in control wells. EBA titers ≥1:10 were considered positive.

The second aliquot of plasma was shipped to AWL for IFA IgY testing. Fixed slides with the C. trachomatis inclusion stage (previously grown in McCoy cells on IFA slides under 5% CO2 and 37°C in Modified Eagle’s medium (MEM) with supplements) were stored at -70°C and evaluated using a previously published method [38]. A titer >1:25 was considered positive [38].

Statistical analysis

The prevalence of raptors with antibodies against Chlamydia spp. and chlamydial DNA detection by qPCR were estimated overall and for each center separately. Associations between Chlamydia spp. infection, serological status and putative risk factors for infection were analyzed using Chi-square tests of independence. Risk factors evaluated included: (1) species; (2) age class: nestling (nestling, pre-fledge, and branchling), hatch year/juvenile (fledglings and 1st year birds), and adult, (3) season of admission—fall (September–November), winter (December–February), spring (March–May), and summer (June–September), (4) rehabilitation center, and (5) region (northern, central, and southern CA). Demographic and environmental variables associated with infection or seropositivity (p ≤ 0.1) were further evaluated using multivariable logistic regression models. Sex was excluded from the multivariable analyses as it was undetermined for the majority (n = 196) of birds. Potentially confounding variables and interactions were evaluated in the models. A variable was considered to be confounding if there was a ≥ 10% change between the adjusted and unadjusted estimates of the odds ratios for other variables in the model. Final parsimonious models were selected by comparing Akaike’s Information Criterion (AIC) among competing models. Adjusted odds ratios with 95% confidence intervals were estimated to assess the strength of the association between risk factors and chlamydial status. All statistical tests were performed with R statistical software version 3.4.2 [39].

Temporal and spatial statistical analyses

Locations at which the birds were found were manually geocoded from zip code data using Google Earth version 5.2 (Google Inc, Mountain View, California, USA). Latitude and longitude coordinates recorded using the WGS 84 geographic coordinate system were converted to decimal degrees. Clustering of seropositive birds and birds testing positive for chlamydial DNA was evaluated using the Bernoulli model and purely spatial and purely temporal scan statistics in SatScanTM version 9.0 [40]. Locations of sampled birds and statistically significant clusters were mapped using ArcGIS® (ESRI, Redlands, California, USA).

Results

Chlamydial DNA was sampled from 263 raptors representing 18 species. The number of birds sampled from each rehabilitation center was: CRC (n = 43), MSPCA (n = 54), PWC (n = 79), CWC (n = 53) and LD (n = 34).

Sequencing and bioinformatic analysis

The sequencing results were nearly identical to the recently described C. buteonis sequence isolated from a RSHA [10]. Phylogenetic analysis revealed that the organisms cultured from SWHA (IDL16-5840) and RTHA (IDL17-4553) were most similar to the recently described C. buteonis sequence. This analysis supported the inclusion of the SWHA and RTHA isolates in the clade containing C. buteonis as determined by Laroucau et al. [10], which is a phylogenetically intermediate between C. psittaci and C. abortus (Fig 1); comparison between the recently described C. buteonis sequence [10] and the SWHA and RTHA isolates revealed 99.97% ANI.

Fig 1. Maximum likelihood phylogenetic tree showing that the SWHA and RTHA isolates were most similar to C. buteonis.

Fig 1

The tree was computed using programs IQtree [33]+ ModelFinder [34] with 1000 iterations of bootstrapping from a pan-genomic analysis using Anvi’o [35] based on aligned protein sequences from all shared sing copy gene clusters.

Quantitative PCR

Swab specimens from 11/263 (4.18%) raptors were positive on Chlamydia spp. qPCR but were not characteristic for C. psittaci and were identified as “atypical positive;” all 11 positive chlamydial samples were also positive using C. buteonis primers (Table 1). Sanger sequencing from qPCR positive amplicons were identical to the recently described C. buteonis sequence [10]. Positive qPCR samples were identified in 6.4% of qPCR positive birds taxonomically classified in the family Accipitridae and 2.0% in the family Strigidae (Table 1). Further, the most detected qPCR positive species was RTHA (n = 8), followed by SWHA (n = 1), Cooper’s hawk (Accipiter cooperii; COHA) (n = 1), and Great horned owl (Bubo virginianus; GHOW) (n = 1) (Table 1). Although positive qPCR results were more commonly detected in RTHAs, differences in prevalence across species and taxonomic families were not statistically significant (p = 0.798, p = 0.060, respectively). Additionally, positive qPCR prevalence was similar across age classes including 3.04% hatch years (n = 8), 0.38% juveniles (n = 1), and 0.76% adults (n = 2) (Table 2). However, significant seasonal differences for positive qPCR samples were identified (p = 0.002). The greatest number of positive birds were admitted in winter (n = 7), followed by spring (n = 2), summer (n = 2), and fall (n = 0) (Table 2). Birds admitted in the winter season were 8.1 times more likely to be qPCR positive than birds admitted during other seasons (OR = 8.1, 95% CI: 2.3–29.1).

Table 1. Results for chlamydial DNA and serology (elementary body agglutination; EBA and immunofluorescent antibody; IFA) by raptor species.

qPCR EBA IFA
Family Bird Species n Positive n Positive n Positive
Accipitridae Bald Eagle 1 0 1 0 1 0
Cooper’s hawk 43 1 (2.3%) 34 1 (2.9%) 34 0
Rough-legged hawk 1 0 1 0 1 0
Red-shouldered hawk 27 0 19 0 18 0
Red-tailed hawk 70 8 (11.4%) 56 10 (17.9%) 55 9 (16.4%)
Swainson’s hawk 11 1 (9.0%) 5 1 (20.0%) 6 0
White-tailed kite 2 0 2 0 2 0
NA-hawk 1 0 1 0 1 0
Subtotal 156 10 (6.4%) 119 12 (10.1%) 118 9 (7.6%)
Cathartidae Turkey Vulture 9 0 7 1 7 0
Subtotal 9 0 (0.0%) 7 1 (14.3%) 7 0 (0.0%)
Falconidae American Kestrel 4 0 2 0 2 0
Merlin 1 0 0 0 0 0
Peregrine falcon 3 0 2 0 1 0
Prairie falcon 1 0 1 1 (100.0%) 1 1 (100.0%)
Subtotal 9 0 (0.0%) 5 1 (20.0%) 4 1 (25.0%)
Pandionidae Osprey 1 0 0 0 0 0
Subtotal 1 0 (0.0%) 0 0 (0.0%) 0 0 (0.0%)
Strigidae Burrowing owl 2 0 0 0 0 0
Great horned owl 46 1 (2.2%) 36 1 (2.7%) 35 1 (2.8%)
Long-eared owl 1 0 0 0 0 0
Western screech owl 1 0 1 0 1 0
Subtotal 50 1 (2.0%) 37 1 (2.7%) 36 1 (2.8%)
Tytonidae Barn owl 38 0 22 0 21 0
Subtotal 38 0 (0.0%) 22 0 (0.0%) 21 0 (0.0%)

Numbers of positive birds for each species are presented with the percentage testing positive in parenthesis below the number.

Table 2. Comparative risk factors for raptors for positive qPCR (n = 263), elementary body agglutination antibodies (EBA; n = 190), or immunofluorescent antibodies (IFA; n = 186) with species, age class, wildlife rehabilitation center, and season of admission.

Patient Information Test Results
Bird ID Center Species Season Sex Age qPCR EBA IFA
62 MSPCA RTHA W NA HY + NA NA
63 MSPCA RTHA W NA HY + NA NA
64 MSPCA RTHA W NA A + +
65 MSPCA RTHA W NA A + + +
226 PWC GHOW S NA HY +
232 PWC RTHA S M HY +
236 PWC RTHA S NA HY +
246 PWC RTHA W NA HY + +
254 PWC GHOW F NA HY +
263 PWC TUVU F NA HY +
303 PWC RTHA P M HY NA +
307 PWC GHOW P M HY +
341 PWC RTHA W NA HY + NA
412 LD COHA S NA HY +
644 CWC SWHA F NA A +
804 CRC COHA S NA NA +
811 CRC RTHA S F A + +
813 CRC RTHA S NA HY +
815 CRC RTHA S NA HY + +
816 CRC RTHA S M A + +
824 CRC RTHA P NA A + +
826 CRC RTHA W NA A + +
861 CRC PRFA F F A +
931 CRC RTHA P NA A +
1001 CRC RTHA P M HY + +
1002 CRC SWHA P F J + NA NA
1003 CRC RTHA W M HY + NA NA

Sex was excluded as this variable was undetermined for the majority (n = 196) of birds.

MSPCA: Monterey SPCA, PWC: Pacific Wildlife Center, LD: Living Desert, CRC: California Raptor Center. RTHA: Red-tailed hawk; GHOW: Great horned owl; TUVU: Turkey vulture; COHA: Cooper’s hawk; SWHA: Swainson’s hawk; PRFA: Prairie falcon. F = Fall, W = Winter, P = Spring, S = Summer. HY = Hatch year, J = Juvenile, A = Adult. +: Positive result, -: Negative result, NA: Test was not performed/result was not determined.

Positive qPCR samples were identified from 3/43 (6.98%) birds admitted to CRC (2 RTHAs, 1 SWHA), 4/54 (7.41%) birds from MSPCA (4 RTHAs), 3/79 (3.80%) birds from PWC (1 Great Horned Owl [Bubo virginianus; GHOW], 2 RTHAs), and 1/34 (2.94%) birds from LD (1 Cooper’s hawk (Accipiter cooperii; COHA; Table 2). No C. buteonis qPCR positives were detected in birds admitted to CWC. This corresponded to prevalence estimates of 6.98% (3/43) in northern CA, 5.26% (7/133) in central CA, and 1.15% (1/87) in southern CA; however, the differences across centers or regions were not statistically significant based on bivariate analyses (p = 0.318, p = 0.190, respectively).

A significant spatial cluster of raptors positive for C. buteonis DNA by qPCR (p = 0.002) was detected in northern CA, extending 24.5 km from its center at 38.310500 N, 121.901800 W and encompassing communities between Sacramento and San Francisco (Fig 2). A significant temporal cluster of raptors testing positive for C. buteonis DNA was detected during the winter season lending further support to the seasonal pattern of infections.

Fig 2. Map of the significant spatial cluster for raptors testing positive for Chlamydia spp. DNA by rt-qPCR in northern California.

Fig 2

Distribution of raptors testing positive (blue) and negative (yellow; Center, 38.310500 N, 121.901800 W).

Serology

In total, 15 of 190 (7.89%) plasma samples were positive for isolate-specific anti-chlamydial EBA antibodies. Two birds positive via EBA had Chlamydia spp. qPCR positive results (Table 1). Complementary to the qPCR results, the EBA and IFA seroprevalences did not differ by taxonomic family (p = 0.245, p = 0.229, respectively). In the family Accipitridae, 10.1% of EBA samples were positive and 14.3% in the family Cathartidae, 20.0% in the family Falconidae and 2.7% in the family Strigidae were also positive (Table 1). Meanwhile, IFA results showed 7.6% of EBA positive birds were classified in the family Accipitridae, 25% in the family Falconidae, and 2.8% in the family Strigidae (Table 1). The most seropositive species via EBA and IFA was the RTHA (n = 10 and 9, respectively), followed by SWHA (n = 1 and 0 respectively), COHA (n = 1 and 0 respectively), Turkey vulture (Cathartes aura; TUVU) (n = 1 and 0 respectively), Prairie falcon (Falco mexicanus Schlegel; PRFA) (n = 1 and 1 respectively), and GHOW (n = 1 and 1 respectively), (Table 1). Seroprevalence by EBA and IFA varied according to age (p = 0.006, p = 0.035, respectively) with the highest seroprevalence in adult birds (EBA: 50.0% adults, 42.8% hatch years/juveniles, 0% nestlings; IFA: 54.5% adults, 45.4% hatch years/juveniles, 0% nestlings). Adult birds were 3.5 times more likely to be seropositive by EBA (OR = 3.5; 95% CI: 1.1, 11.4) than juvenile birds (hatch years and nestlings). Age class was not statistically significant in the logistic regression model for seropositivity by IFA; however, age class was included in the final IFA model to adjust for confounding. Seroprevalence by EBA and IFA were not variable by season (p = 0.776, p = 0.412, respectively).

Eight of 28 (28.57%) birds from the CRC, 1/14 (7.14%) birds from MSPCA, 5/74 (6.76%) birds from PWC, 0/53 (0%) birds from CWC, and 0/21 (0%) birds from LD were EBA seropositive (Table 1). Differences in seroprevalence by EBA varied significantly across centers and regions (both p < 0.001) with the highest seropositivity in northern CA (28.57%), then central CA (6.82%), and southern CA (1.35%). Birds admitted to centers in northern CA were 5.6 times more likely to be seropositive by EBA (OR = 5.6; 95% CI: 1.7, 18.9) than other regions. Eleven of 186 (5.91%) birds were seropositive by Chlamydia genus-specific IFA (Table 2). Positive IFA results from 6/11 samples correlated with positive EBA results and three positive IFA birds had positive Chlamydia spp. qPCR positive results (Table 2). One qPCR positive RTHA was also positive for both EBA and IFA antibodies (Table 2).

Seroprevalence of IFA by rehabilitation center was: CRC: 7/28 (25.00%), MSPCA: 2/14 (14.29%), PWC: 2/72 (2.78%), CWC: 0/51 (0%), and LD: 0/21 (0%). IFA seroprevalences were estimated to be 25% in northern CA, 4.65% in central CA and 0% in southern CA. Differences in prevalence of anti-chlamydial antibodies by IFA across centers and regions were statistically significant (both p < 0.001). Birds in northern CA were 11.3 times more likely to be seropositive by IFA (OR = 11.3; 95% CI: 2.8, 45.3) than birds in other regions.

A significant spatial cluster of seropositive raptors (EBA and/or IFA) was detected (p = 0.001) in the same area (center at 38.310500 N, 121.901800 W) as the qPCR positive raptors, but encompassed a larger area, extending 42.40 km from its center (Fig 3). A significant temporal cluster of raptors testing positive for chlamydial DNA was detected during the winter season lending further support to the seasonal pattern of infections.

Fig 3. Map of the significant spatial cluster of Chlamydia spp. seropositive raptors by EBA and/or IFA in northern California.

Fig 3

Distribution of seropositive raptors (blue) and seronegative raptors (yellow; Center, 38.310500 N, 121.901800 W).

Nine of 11 (81.82%) birds positive by qPCR had physical examination findings recorded upon presentation. Clinical manifestations in infected birds were non-specific and included dehydration (8/9 birds) and co-infection with feather lice (5/9 birds). Most EBA seropositive birds were dehydrated (9/14) and all seropositive birds had a variety of traumatic injuries (e.g., wing injuries) and co-infections including coccidiosis, trichomoniasis, and avian pox.

Discussion

Chlamydial DNA prevalence in raptors admitted to rehabilitation centers across CA was identified as “atypical” using C. psittaci primers and targeted PCR along with Sanger sequencing confirmed C. buteonis from the qPCR “atypical” positive DNA samples. Further, whole genome sequencing analysis performed on EBs from bacterial isolates from two raptors confirmed that the chlamydial isolate had a 99.97% ANI to C. buteonis, a newly identified species [10]. This is notable as the RSHA isolate was identified in France, whereas these isolates were identified in CA, USA. Isolate-specific EBA methodology was performed to investigate for IgM serological prevalence. One COHA and one GHOW had positive qPCR and antibody results; neither bird is in the genus Buteo. While previous research reported that C. buteonis has only been identified in the Buteo genus (RSHA), this study demonstrates that C. buteonis DNA was detected in other raptor hosts including a GHOW and detectable antibodies were identified in a TUVU, PRFA, and GHOW. These findings highlight the need for additional studies to evaluate diversity as well as pathogenicity and zoonotic potential of chlamydial species infecting raptors.

Chlamydial qPCR prevalence reported here (4.18%) is similar to data from raptors admitted to Oregon wildlife rehabilitation centers [13], and is higher than that found in free-ranging Buteo spp. in CA [14]. Similarities in prevalence between these studies could be explained by similar geographical locations of study populations or prey species available in Oregon and northern/central CA. Chlamydial qPCR prevalence was similar between free-ranging raptors in Sweden (1.3%) and northern CA (1.37%) [14,41]. The majority of raptors admitted to rehabilitation centers are sick or injured, thus chlamydial spp. infections would be expected to be higher than in free-ranging, presumably healthy birds. Meanwhile, a lower seroprevalence was detected in the study reported here than from raptors in Germany (63%) and previously from northern CA (44%) [11,42]; however, different testing methodologies for C. psittaci were utilized in those studies. The findings reported here may also differ from previous studies due to time of infection, immune response or handling artifacts. Moreover, a final sample size of 250 birds/center was anticipated based on previous intake numbers. However, centers reported lower intake numbers during the study leading to a smaller sample size of approximately 25% of expected.

Most birds qPCR-positive for Chlamydia DNA had negative serological results. This could result from detection of exogenous DNA from environmental contamination, plasma samples acquired before an immune response could be mounted or immunosuppression due to co-infections, toxins, drought or lack of prey. Because a single swab from multiple mucosal surfaces was analyzed for chlamydial DNA, the primary source of the organism cannot be determined. Multiple birds that were EBA seronegative were IFA seropositive, possibly due to birds being in the chronic stage of infection [28].

There were significant spatial clusters of Chlamydia DNA positive and seropositive birds detected in northern CA. It is possible that this chlamydial organism is confined to populations of raptors in northern, and to a lesser degree, central CA. An alternative explanation is that raptors are exposed to chlamydial organisms from infected dietary items that are more commonly found in these regions. In addition, chlamydial DNA prevalence and seroprevalence was highest in, but not exclusive to, RTHAs. Red-tailed hawks are one of the most abundant raptors within the CA central valley and constituted 26.6% of the sample population. The primary RTHA diet in the CA central valley consists of ground squirrels (Spermophilus spp.) black-tailed jackrabbits (Lepus californicus) and pocket gophers (Geomys spp., Thomomys spp.), although other mammals, small birds and reptiles have been reported [43]. It is possible that free-ranging rodents or rabbits may be a source of a chlamydial organism capable of infecting raptors. To the authors´ knowledge, there are no reports confirming chlamydial organisms in these prey species.

Chlamydial qPCR positive prevalence was highest in birds presented during the winter, and seroprevalence increased with age. The higher prevalence in winter months could be associated with environmental stressors leading to reduced immunity. For example, rehabilitators often receive juvenile raptors emaciated with secondary infections during the winter [44]. It is also possible that raptors are increasingly exposed to the organism due to prey shifts in winter months. Birds testing positive for chlamydial DNA presented with nonspecific clinical signs, and all seropositive birds suffered from traumatic injuries and/or co-infections. Oregon rehabilitation centers reported similar co-morbidities with positive chlamydial DNA birds [13]. Positive birds reported here had common conditions such as pediculosis and dehydration; however, these conditions are common in ill raptors, regardless of the underlying condition. Correlations of clinicopathologic test results with Chlamydia-specific testing would be beneficial. Further epidemiological studies are needed to better understand hosts and transmission of this organism.

To our knowledge, this is the first prospective study assessing chlamydial DNA prevalence and seroprevalence in raptors admitted to wildlife rehabilitation centers in the US. Understanding the prevalence of this organism in rehabilitation centers is important because of its potentially high transmission rate to other birds and its relationship to other Chlamydia spp. with known zoonotic potential. Chlamydial infections in raptors can be problematic for individuals in contact with birds, including rehabilitation center staff, wildlife biologists, veterinarians and falconers [20,21]. Suspected zoonotic transmission of a chlamydial infection to volunteers at a rehabilitation center highlighted that wildlife rehabilitation workers were unaware of the symptoms of chlamydiosis [19]. Understanding the prevalence and risk factors associated with this pathogen aids in education and outreach to at-risk individuals regarding its zoonotic potential and prevention. The detection of atypical chlamydial organisms in wild raptors could also be of importance in the management of threatened or endangered species. Chlamydial bacteria can spread to other avian species, including sympatric avian populations such as SWHAs, a threatened raptor population in CA.

Conclusion

This study reports the prevalence and risk factors associated with a recently characterized chlamydial species in raptors presenting to wildlife rehabilitation centers in CA, USA. Previous research identified C. buteonis in a RSHA; however, this study shows that C. buteonis has a larger host range that expands to other raptor families in addition to Accipitridae including Falconidae, Strigidae and Cathartidae. Information generated through this study will enhance awareness among wildlife rehabilitation staff of chlamydial infections in raptors and guide in assessments of admitted birds. These results demonstrate that the current understanding of chlamydial infections in raptors is limited and additional studies are needed to fully elucidate the diversity and epidemiology of Chlamydia spp. circulating among raptor populations in CA.

Acknowledgments

The authors thank the veterinarians and staff from the following rehabilitation centers for their sample collection and processing: California Raptor Center, California Wildlife Center, Pacific Wildlife Care, Monterey SPCA, Living Desert.

Data Availability

All relevant data are within the manuscript.

Funding Statement

This study was financially supported through the Karen C. Drayer Wildlife Health Center Fellowship Grant Program, School of Veterinary Medicine, Univ. of California, Davis, Davis, CA and the Infectious Disease Laboratory, College of Veterinary Medicine, University of Georgia, Athens, GA. The Karen C. Drayer Wildlife Health Center funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Infectious Disease Laboratory, University of GA donated the costs of the qPCR testing, EBA testing and chlamydial cultures and were instrumental in data analysis, decision to publish and preparation of the manuscript. Multiple authors are affiliated with the laboratory (Ritchie, Nilsen, Ciembor, Pesti, Gregory) but only Ritchie and Nilsen were involved in manuscript preparation.

References

  • 1.Sachse K, Laroucau K, Vanrompay D. Avian chlamydiosis. Current Clin Microbiol Rep. 2015:1–12. [Google Scholar]
  • 2.Read TD, Joseph SJ, Didelot X, Liang B, Patel L, Dean D. Comparative analysis of Chlamydia psittaci genomes reveals the recent emergence of a pathogenic lineage with a broad host range. MBio. 2013;4(2). doi: 10.1128/mBio.00604-12 ; PubMed Central PMCID: PMC3622922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wolff BJ, Morrison SS, Pesti D, Ganakammal SR, Srinivasamoorthy G, Changayil S, et al. Chlamydia psittaci comparative genomics reveals intraspecies variations in the putative outer membrane and type III secretion system genes. Microbiology. 2015;161(7):1378–91. doi: 10.1099/mic.0.000097 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bachmann NL, Fraser TA, Bertelli C, Jelocnik M, Gillett A, Funnell O, et al. Comparative genomics of koala, cattle and sheep strains of Chlamydia pecorum. BMC Genomics. 2014;15:667. Epub 2014/08/12. doi: 10.1186/1471-2164-15-667 ; PubMed Central PMCID: PMC4137089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sachse K, Bavoil PM, Kaltenboeck B, Stephens RS, Kuo C-C, Rosselló-Móra R, et al. Emendation of the family Chlamydiaceae: Proposal of a single genus, Chlamydia, to include all currently recognized species. Systematic and Applied Microbiology. 2015;(0). doi: 10.1016/j.syapm.2014.12.004 [DOI] [PubMed] [Google Scholar]
  • 6.Staub E, Marti H, Biondi R, Levi A, Donati M, Leonard CA, et al. Novel Chlamydia species isolated from snakes are temperature-sensitive and exhibit decreased susceptibility to azithromycin. Sci Rep. 2018;8(1):5660. Epub 2018/04/06. doi: 10.1038/s41598-018-23897-z ; PubMed Central PMCID: PMC5884828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Laroucau K, Aaziz R, Lecu A, Laidebeure S, Marquis O, Vorimore F, et al. A cluster of Chlamydia serpentis cases in captive snakes. Vet Microbiol. 2020;240:108499. Epub 2020/01/07. doi: 10.1016/j.vetmic.2019.108499 . [DOI] [PubMed] [Google Scholar]
  • 8.Vorimore F, Hsia RC, Huot-Creasy H, Bastian S, Deruyter L, Passet A, et al. Isolation of a New Chlamydia species from the Feral Sacred Ibis (Threskiornis aethiopicus): Chlamydia ibidis. PLoS One. 2013;8(9):e74823. doi: 10.1371/journal.pone.0074823 ; PubMed Central PMCID: PMC3779242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Taylor-Brown A, Ruegg S, Polkinghorne A, Borel N. Characterisation of Chlamydia pneumoniae and other novel chlamydial infections in captive snakes. Vet Microbiol. 2015;178(1–2):88–93. doi: 10.1016/j.vetmic.2015.04.021 . [DOI] [PubMed] [Google Scholar]
  • 10.Laroucau K, Vorimore F, Aaziz R, Solmonson L, Hsia RC, Bavoil PM, et al. Chlamydia buteonis, a new Chlamydia species isolated from a red-shouldered hawk. Syst Appl Microbiol. 2019;42(5):125997. Epub 2019/07/02. doi: 10.1016/j.syapm.2019.06.002 . [DOI] [PubMed] [Google Scholar]
  • 11.Fowler ME, Schulz T, Ardans A, Reynolds B, Behymer D. Chlamydiosis in captive raptors. Avian Dis. 1990;34(3):657–62. . [PubMed] [Google Scholar]
  • 12.Mirande LA, Howerth EW, Poston RP. Chlamydiosis in a red-tailed hawk (Buteo jamaicensis). J Wildl Dis. 1992;28(2):284–7. Epub 1992/04/01. doi: 10.7589/0090-3558-28.2.284 . [DOI] [PubMed] [Google Scholar]
  • 13.Jouffroy SJ, Schlueter AH, Bildfell RJ, Rockey DD. Rhabdochlamydia spp. in an Oregon raptor. J Vet Diagn Invest. 2016;28(4):473–6. doi: 10.1177/1040638716646408 . [DOI] [PubMed] [Google Scholar]
  • 14.Lujan-Vega C, Hawkins MG, Johnson CK, Briggs C, Vennum C, Bloom PH, et al. Atypical Chlamydiaceae in wild populations of hawks (Buteo Spp.) in California. J Zoo Wildl Med. 2018;49(1):108–15. Epub 2018/03/09. doi: 10.1638/2017-0053R.1 . [DOI] [PubMed] [Google Scholar]
  • 15.Burnard D, Polkinghorne A. Chlamydial infections in wildlife-conservation threats and/or reservoirs of ’spill-over’ infections? Vet Microbiol. 2016;196:78–84. Epub 2016/12/13. doi: 10.1016/j.vetmic.2016.10.018 . [DOI] [PubMed] [Google Scholar]
  • 16.Kim H, Kwak W, Yoon SH, Kang DK, Kim H. Horizontal gene transfer of Chlamydia: Novel insights from tree reconciliation. PLoS One. 2018;13(4):e0195139. Epub 2018/04/06. doi: 10.1371/journal.pone.0195139 ; PubMed Central PMCID: PMC5886423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Taylor-Brown A, Polkinghorne A. New and emerging chlamydial infections of creatures great and small. New Microbes New Infect. 2017;18:28–33. doi: 10.1016/j.nmni.2017.04.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Smith KA, Campbell CT, Murph yJ, Stobierski MG, Tengelsen TA. Compendium of measures to control Chlamydophila psittaci infection among humans (psittacosis) and pet birds (avian chlamydiosi). J Exot Pet Med. 2011;20:32–45. [Google Scholar]
  • 19.Kalmar ID, Dicxk V, Dossche L, Vanrompay D. Zoonotic infection with Chlamydia psittaci at an avian refuge centre. Vet J. 2014;199(2):300–2. doi: 10.1016/j.tvjl.2013.10.034 . [DOI] [PubMed] [Google Scholar]
  • 20.Beeckman DSA, Vanrompay D. Zoonotic Chlamydophila psittaci infections from a clinical perspective. Clinical microbiology and infection. 2009;15(1):11–7. doi: 10.1111/j.1469-0691.2008.02669.x [DOI] [PubMed] [Google Scholar]
  • 21.Harkinezhad T, Geens T, Vanrompay D. Chlamydophila psittaci infections in birds: a review with emphasis on zoonotic consequences. Vet Microbiol. 2009;135(1–2):68–77. doi: 10.1016/j.vetmic.2008.09.046 . [DOI] [PubMed] [Google Scholar]
  • 22.Heddema ER, van Hannen EJ, Duim B, de Jongh BM, Kaan JA, van Kessel R, et al. An outbreak of psittacosis due to Chlamydophila psittaci genotype A in a veterinary teaching hospital. J Med Microbiol. 2006;55(Pt 11):1571–5. Epub 2006/10/13. doi: 10.1099/jmm.0.46692-0 . [DOI] [PubMed] [Google Scholar]
  • 23.Balsamo G, Maxted AM, Midla JW, Murphy JM, Wohrle R, Edling TM, et al. Compendium of Measures to Control Chlamydia psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017. J Avian Med Surg. 2017;31(3):262–82. Epub 2017/09/12. doi: 10.1647/217-265 . [DOI] [PubMed] [Google Scholar]
  • 24.Sachse K, Vretou E, Livingstone M, Borel N, Pospischil A, Longbottom D. Recent developments in the laboratory diagnosis of chlamydial infections. Vet Microbiol. 2009;135(1–2):2–21. doi: 10.1016/j.vetmic.2008.09.040 . [DOI] [PubMed] [Google Scholar]
  • 25.(OIE) WOfAH. Avian Chlamydiosis. In: OIE, editor. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. France: OIE; 2018. [Google Scholar]
  • 26.Madani SA, Peighambari SM. PCR-based diagnosis, molecular characterization and detection of atypical strains of avian Chlamydia psittaci in companion and wild birds. Avian Pathol. 2013;42(1):38–44. doi: 10.1080/03079457.2012.757288 . [DOI] [PubMed] [Google Scholar]
  • 27.Mitchell SL, Wolff BJ, Thacker WL, Ciembor PG, Gregory CR, Everett KD, et al. Genotyping of Chlamydophila psittaci by real-time PCR and high-resolution melt analysis. J Clin Microbiol. 2009;47(1):175–81. doi: 10.1128/JCM.01851-08 ; PubMed Central PMCID: PMC2620869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ritchie B. Avian Chlamydiosis A laboratory Manual for the Isolation, Identification and Characterization of Avian Pathogens (6th edition): AAAP; 2016. p. 23–32. [Google Scholar]
  • 29.Andrews S. FastQC: a quality control tool for high throughput sequence data. Babraham Bioinformatics, Babraham Institute, Cambridge, United Kingdom; 2010. [Google Scholar]
  • 30.Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet journal. 2011;17(1):10–2. [Google Scholar]
  • 31.Zerbino DR. Using the Velvet de novo assembler for short‐read sequencing technologies. Current protocols in bioinformatics. 2010;31(1):11.5. 1–.5. 2. doi: 10.1002/0471250953.bi1105s31 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Pritchard L, Glover RH, Humphris S, Elphinstone JG, Toth IK. Genomics and taxonomy in diagnostics for food security: soft-rotting enterobacterial plant pathogens. Analytical Methods. 2016;8(1):12–24. [Google Scholar]
  • 33.Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, von Haeseler A, et al. IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era. Mol Biol Evol. 2020;37(5):1530–4. Epub 2020/02/06. doi: 10.1093/molbev/msaa015 ; PubMed Central PMCID: PMC7182206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kalyaanamoorthy S, Minh BQ, Wong TKF, von Haeseler A, Jermiin LS. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat Methods. 2017;14(6):587–9. Epub 2017/05/10. doi: 10.1038/nmeth.4285 ; PubMed Central PMCID: PMC5453245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Delmont TO, Eren AM. Linking pangenomes and metagenomes: the Prochlorococcus metapangenome. PeerJ. 2018;6:e4320. Epub 2018/02/10. doi: 10.7717/peerj.4320 ; PubMed Central PMCID: PMC5804319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Dusek RJ, Justice-Allen A, Bodenstein B, Knowles S, Grear DA, Adams L, et al. Chlamydia psittaci in feral rosy-faced lovebirds (Agapornis roseicollis) and other backyard birds in Maricopa County, Arizona USA J Wildl Dis. 2018;54(2):248–60. Epub 2018/01/26. doi: 10.7589/2017-06-145 . [DOI] [PubMed] [Google Scholar]
  • 37.Grimes JE, Tully TN Jr., Arizmendi F, Phalen DN. Elementary body agglutination for rapidly demonstrating chlamydial agglutinins in avian serum with emphasis on testing cockatiels. Avian Dis. 1994;38(4):822–31. . [PubMed] [Google Scholar]
  • 38.Bossart GD, Romano TA, Peden-Adams MM, Schaefer A, McCulloch S, Goldstein JD, et al. Clinicoimmunopathologic findings in Atlantic bottlenose dolphins Tursiops truncatus with positive cetacean morbillivirus antibody titers. Dis Aquat Organ. 2011;97(2):103–12. doi: 10.3354/dao02410 . [DOI] [PubMed] [Google Scholar]
  • 39.Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2014. [Google Scholar]
  • 40.Kulldorff M, Nagarwalla N. Spatial disease clusters: detection and inference. Statistics in medicine. 1995;14(8):799–810. Epub 1995/04/30. doi: 10.1002/sim.4780140809 . [DOI] [PubMed] [Google Scholar]
  • 41.Blomqvist M, Christerson L, Waldenstrom J, Herrmann B, Olsen B. Chlamydia psittaci in Swedish wetland birds: a risk to zoonotic infection? Avian Dis. 2012;56(4):737–40. doi: 10.1637/10105-022812-ResNote.1 . [DOI] [PubMed] [Google Scholar]
  • 42.Schettler E, Langgemach T, Sommer P, Streich J, Frolich K. Seroepizootiology of selected infectious disease agents in free-living birds of prey in Germany. J Wildl Dis. 2001;37(1):145–52. Epub 2001/03/29. doi: 10.7589/0090-3558-37.1.145 . [DOI] [PubMed] [Google Scholar]
  • 43.Fitch HS, Swenson F, Tillotson DF. Behavior and Food Habits of the Red-Tailed Hawk. The Condor. 1946;48(5):205–37. doi: 10.2307/1363939 [DOI] [Google Scholar]
  • 44.Graham JE, Heatley JJ. Emergency care of raptors. Vet Clin North Am Exot Anim Pract. 2007;10(2):395–418. Epub 2007/06/20. doi: 10.1016/j.cvex.2007.01.003 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Deborah Dean

7 Sep 2021

PONE-D-21-20941Chlamydia buteonis in birds of prey presented to California wildlife rehabilitation facilitiesPLOS ONE

Dear Dr. Hawkins,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please address each issue raised by the reviewers in a point-by-point response with corrections to the text/tables/figures where indicated.

Please submit your revised manuscript within Oct 22 2021 11:59PM.  If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Deborah Dean, M.D., M.P.H.

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide methods of sacrifice in the Methods section of your manuscript

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

5. Thank you for stating the following financial disclosure:

 “This study was financially supported through the Karen C. Drayer Wildlife Health Center Fellowship Grant Program, School of Veterinary Medicine, Univ. of California, Davis, DAvis, CA.”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

6. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“The authors thank the Wildlife Health Center Fellowship grant program for their financial support of the study and the veterinarians and staff from the following rehabilitation centers for their sample collection and processing: California Raptor Center, California Wildlife Center, Pacific Wildlife Care, Monterey SPCA, Living Desert. We would also like to thank the Infectious Disease Laboratory, University of GA for the generous donation of the qPCR testing, EBA testing and chlamydial cultures and the Avian and Wildlife Laboratory, University of Miami for partial donation of IFA testing.”

We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“This study was financially supported through the Karen C. Drayer Wildlife Health Center Fellowship Grant Program, School of Veterinary Medicine, Univ. of California, Davis, DAvis, CA.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

7. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere. [DETAILS AS NEEDED] Please clarify whether this [conference proceeding or publication] was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript.

8. Please upload a new copy of Figure 1 as the detail is not clear. Please follow the link for more information: " ext-link-type="uri" xlink:type="simple">https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/" https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/.

9. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The findings of this study are new and interesting as they appear shortly after publication of the species Chlamydia buteonis. Samples for serology and qPCR were collected from 263 birds of prey, representing 18 species. Chlamydial DNA was found in 4.18 % and anti-chlamydial Abs detected in 3.14 % of tested birds. As could be expected, a serologic response was typically observed in adults. Nevertheless, the inclusion of serology in parallel to DNA testing is an important asset of the present work. The manuscript is concise and well written. Data processing and presentation are adequate.

A few points remain unclear and should be revised.

1. Line 114: Plasma samples were divided into two aliquots and tested using two serologic assays. Please, indicate the chlamydia species of the hawk isolate used in the assay at the IDL.

2. Line151-52:

a) It is unclear from the text whether both positive cultures from SWHA (IDL16-

5840_SH) and RTHA (IDL17_4553_RTH) were genome sequenced or only one. How many sequences will be (or have been) deposited at NCBI?

b) It seems that complete assembly of the raw sequences has not been achieved as 742 clusters are reported. If so, a reason should be given.

3. Lines 157-59: The qPCR assay for C. buteonis used here is probably new and has not been published previously. If so, the authors should include data showing the specificity of that assay. Besides, the protocol of a specific and sensitive assay can be found in reference 10.

4. Line 207: The authors claim that the clade containing their own C. buteonis isolates is distinctly different from other chlamydial species. However, there is only one more species, C. psittaci, on Fig. 1. The substantiate the statement, at least one more species should appear in the figure, e.g. C. trachomatis as a non-avian Chlamydia sp.

5. In reference 10, only hawks (genus Buteo) were mentioned as known hosts of C. buteonis. The present study revealed new observations on host specificity of this species that should be summarized and included in the text as a major conclusion.

Reviewer #2: The authors present an analysis of detection of chlamydial DNA and/or antibodies in raptors presenting to wildlife rehabilitation centres. The analysis is clear and easy to follow, and the trends apparent related to age, different species are also clearly documented. The sample size of 263 from 18 species is good size, and across several distinct centres. The evidence of increasing serological responses in age and chlamydial DNA associated with disease supports the conclusion of the potential for risk and the prevalence of the organism in these wild populations. The sequence analysis confirming similarity to a recently described c.buteonis adds confidence to the findings. Overall this study is a valid and useful addition to the literature on chlamydia in wildlife.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Willa Huston

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Oct 13;16(10):e0258500. doi: 10.1371/journal.pone.0258500.r002

Author response to Decision Letter 0


20 Sep 2021

Responses to Editorial Comments:

1. We have worked to ensure that all of the formatting conforms to PlosOne.

2. No animals were “sacrificed,” therefore nothing was included in the methods regarding this.

3. I apologize for not initially providing complete information on the minimum dataset, as this is my first PlosOne submission. I have reviewed the entire manuscript and all data necessary to complete statistical analyses are included within the manuscript in the tables and figures. We have no ethical or legal issues with sharing our data. Specifically these 5 items are addressed:

1) Sequences (SWHA (IDL16-5840_SH) and RTHA (IDL17_4553_RTH) were submitted to NCBI BioProject accession number PRJNA613727 (Lines 174, 175 in manuscript)

2) Data for the primers for the qPCR for C. buteonis are within the manuscript (Line 186, 187 in manuscript)

3) Fig 1. Maximum likelihood phylogenetic tree showing that the SWHA and RTHA isolates were most similar to C. buteonis.

4) Tables 1 and 2 provide the raw data for chlamydial DNA and serology (elementary body agglutination; EBA and immunofluorescent antibody; IFA) by raptor species, therefore providing the raw data used for the statistical analyses.

5) Fig 2 and 3. Map of the significant spatial cluster for raptors testing positive for Chlamydia spp. DNA by rt-qPCR in northern California was developed using methods described within the manuscript and using the raw data using the qPCR results from table 2.

4. It is stated that the grant information provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. I updated the “funding information” section but it was not a grant, rather in-kind donation of the qPCR, EBA serology and chlamydial cultures. As several authors are from this laboratory I was unsure how else to clarify? Our new financial disclosure should read “This study was financially supported through the Karen C. Drayer Wildlife Health Center Fellowship Grant Program, School of Veterinary Medicine, Univ. of California, Davis, Davis, CA and the Infectious Disease Laboratory, College of Veterinary Medicine, University of Georgia, Athens, GA.”

5. I would like to update the information regarding the role of funders for this research. The Karen C. Drayer Wildlife Health Center funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Infectious Disease Laboratory, University of GA donated the costs of the qPCR testing, EBA testing and chlamydial cultures and were instrumental in data analysis, decision to publish and preparation of the manuscript. Multiple authors are affiliated with the laboratory (Ritchie, Nilsen, Ciembor, Pesti, Gregory) but only Ritchie and Nilsen were involved in manuscript preparation. We have removed the Avian and Wildlife Laboratory at the Univ. of Miami, as this is a research price given to all researchers and therefore we do not believe now is a source of funding. Please let me know if you disagree?

6. Acknowledgements of funding within the manuscript have been removed (Lines 447-449). The corrected statement reads: “The authors thank the veterinarians and staff from the following rehabilitation centers for their sample collection and processing: California Raptor Center, California Wildlife Center, Pacific Wildlife Care, Monterey SPCA, Living Desert.

7. This work was presented at the 2016 ExoticsCon conference in Portland, OR by my Master’s student Seibert (first author) and was published for association members in their proceedings for that year as a 250 word abstract. The abstract is only reviewed by one person for approval to present at the conference. This is the abstract “Chlamydia psittaci is a reportable, zoonotic bacterium with health implications for birds and humans. Due to its zoonotic potential, veterinary staff should be updated on the prevalence and clinical presentations of Chlamydia spp. infections in raptors. A retrospective study evaluating raptors testing positive for Chlamydial infections was conducted through the UC Davis Veterinary Medical Teaching Hospital medical records from 2004 –2016. A confirmed or probable case was based on the National Association of Public Health Veterinarians criteria for C. psittaci.1 Specific C. psittaci diagnostic testing included real-time PCR (RT-PCR) from a combination mucosal swab, elementary body agglutination testing, indirect fluorescent antibody testing, immunofluorescent antibody staining for Chlamydia spp. antigen, and isolation of the organism. Signalment (sex, age, seasonality and species) and clinicopathologic results from positive cases were analyzed. A Chi-squared test was used to statistically evaluate the data, and significance was defined as p ≤ 0.05. Forty eight red-tailed hawks (RTHA; Buteo jamaicensis) and 1 Swainson’s hawk (B. swainsoni) were identified as confirmed or probable cases. A 22.9% prevalence was identified from the total number of raptors tested for C. psittaci and 1.9% prevalence was identified from the total number of all raptors admitted to the VMTH. There was a significant difference in prevalence between age (p0.005), seasonality (p0.001) and species (p0.001). Tissues most commonly identified as positive were lung, liver, air sac, heart and kidney. Genetic sequencing of tissue samples from two RTHA with conflicting IFA/EBA results suggests that these infections may be caused by a novel Chlamydial-like organism.” We did not feel this 250 word abstract for a conference constituted previous publication.

8. I put figure 1 into the PACE system and it did not find any image problems but did increase the dpi to 300 x 300 and created a proper TIF. I hope this is acceptable? Please let me know if it is not.

9. We reviewed our references. None have been retracted.

Responses to Reviewers:

Thank you for giving us the opportunity to re-submit a revised manuscript of “Chlamydia buteonis in birds of prey presented to California wildlife rehabilitation facilities” for PlosOne. We appreciate yours along with the reviewers’ time and effort spent providing feedback and insightful comments to help improve our manuscript. We have incorporated most of the suggestions made by you and the reviewers. Please see below a point-by-point response to the reviewers’ comments and concerns. Line numbers refer to the revised manuscript file with tracked changes.

5. Review Comments to the Author

Reviewer #1: The findings of this study are new and interesting as they appear shortly after publication of the species Chlamydia buteonis. Samples for serology and qPCR were collected from 263 birds of prey, representing 18 species. Chlamydial DNA was found in 4.18 % and anti-chlamydial Abs detected in 3.14 % of tested birds. As could be expected, a serologic response was typically observed in adults. Nevertheless, the inclusion of serology in parallel to DNA testing is an important asset of the present work. The manuscript is concise and well written. Data processing and presentation are adequate.

A few points remain unclear and should be revised.

1. Line 114: Plasma samples were divided into two aliquots and tested using two serologic assays. Please, indicate the chlamydia species of the hawk isolate used in the assay at the IDL.

Author Response: Thank you, the species of the hawk isolates used were added.

2. Line151-52:

a) It is unclear from the text whether both positive cultures from SWHA (IDL16-

5840_SH) and RTHA (IDL17_4553_RTH) were genome sequenced or only one. How many sequences will be (or have been) deposited at NCBI?

Author Response: Thank you, both positive cultures were sequenced, and this information was added. Two sequences have been deposited at NCBI under the BioProject accession number PRJNA613727.

b) It seems that complete assembly of the raw sequences has not been achieved as 742 clusters are reported. If so, a reason should be given.

Author Response: Thank you, the Anvi'o software determined 742 single copy genes that were distinguishable as homologous between all the genomes and determined to be single copy genes in all the genomes; and therefore, used for the phylogenetic analysis. This was not a measure of completeness of any genome, just the number of genes that were used in the phylogenetic analysis. The description of the methods was updated in the manuscript.

3. Lines 157-59: The qPCR assay for C. buteonis used here is probably new and has not been published previously. If so, the authors should include data showing the specificity of that assay. Besides, the protocol of a specific and sensitive assay can be found in reference 10.

Author Response: Thank you, we expanded on the flow of the C. buteonis identification in the positive samples within the method section. The samples were first analysed using the C. psittaci specific qPCR with a melting curve analysis following a previously described method. However, the positive samples from this study showed a different melting curve signature compared to C. psittaci positive control samples. Thus, those samples were amplified using C. buteonis specific primers described in the method section and then Sanger sequenced to confirm C. buteonis identity.

4. Line 207: The authors claim that the clade containing their own C. buteonis isolates is distinctly different from other chlamydial species. However, there is only one more species, C. psittaci, on Fig. 1. To substantiate the statement, at least one more species should appear in the figure, e.g. C. trachomatis as a non-avian Chlamydia sp.

Author Response: Thank you, we understand that the conclusion suggested results showing more than 1 species and therefore edited the results section of Figure 1 to state the following “This analysis supported the inclusion of the SWHA and RTHA isolates in the clade containing C. buteonis as determined by Laroucau et al, which is a phylogenetically intermediate between C. psittaci and C. abortus.”

5. In reference 10, only hawks (genus Buteo) were mentioned as known hosts of C. buteonis. The present study revealed new observations on host specificity of this species that should be summarized and included in the text as a major conclusion.

Author Response: Thank you. This finding was emphasized in the abstract, discussion and conclusion.

Reviewer #2: The authors present an analysis of detection of chlamydial DNA and/or antibodies in raptors presenting to wildlife rehabilitation centres. The analysis is clear and easy to follow, and the trends apparent related to age, different species are also clearly documented. The sample size of 263 from 18 species is good size, and across several distinct centres. The evidence of increasing serological responses in age and chlamydial DNA associated with disease supports the conclusion of the potential for risk and the prevalence of the organism in these wild populations. The sequence analysis confirming similarity to a recently described c.buteonis adds confidence to the findings. Overall this study is a valid and useful addition to the literature on chlamydia in wildlife.

Thank you so much for your review.

Attachment

Submitted filename: 2021_PlosOne_Response to Reviewers FINAL.docx

Decision Letter 1

Deborah Dean

29 Sep 2021

Chlamydia buteonis in birds of prey presented to California wildlife rehabilitation facilities

PONE-D-21-20941R1

Dear Dr. Hawkins,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Deborah Dean, M.D., M.P.H.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Deborah Dean

4 Oct 2021

PONE-D-21-20941R1

Chlamydia buteonis in birds of prey presented to California wildlife rehabilitation facilities

Dear Dr. Hawkins:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Deborah Dean

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: 2021_PlosOne_Response to Reviewers FINAL.docx

    Data Availability Statement

    All relevant data are within the manuscript.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES